Immunogenicity and safety of BNT162b2 COVID‐19 vaccine in a chronic lymphocytic leukaemia patient

Detalles Bibliográficos
Autores principales: Agrati, Chiara, Castilletti, Concetta, Sacchi, Alessandra, Colavita, Francesca, Capobianchi, Maria Rosaria, Puro, Vincenzo, Nicastri, Emanuele, Ippolito, Giuseppe, Bibas, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242718/
https://www.ncbi.nlm.nih.gov/pubmed/34032357
http://dx.doi.org/10.1111/jcmm.16565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242718/
https://www.ncbi.nlm.nih.gov/pubmed/34032357
http://dx.doi.org/10.1111/jcmm.16565

Ejemplares similares